Physiomics(GB:PYC)
GBXÂ 0.430.00 (0.00%)
GB:PYC
Physiomics financials statements
GBXÂ 0.43
At close:0.00 (0.00%)
Want to see GB:PYC full AI Analyst Report?
Physiomics (PYC) Ratios
7 Followers
Physiomics Ratios
GB:PYC's free cash flow for Q4 2025 was £-362.17K. For the 2025 fiscal year, GB:PYC's free cash flow was decreased by £-2.43K and operating cash flow was £-359.74K. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.88 | 4.38 | 2.87 | 4.63 | 7.81 |
| Quick Ratio | 2.88 | 4.38 | 2.87 | 4.63 | 7.81 |
| Cash Ratio | 1.58 | 2.31 | 1.36 | 2.92 | 4.89 |
| Solvency Ratio | -2.60 | -2.03 | -4.29 | -3.27 | -1.72 |
| Operating Cash Flow Ratio | -2.12 | -2.73 | -3.91 | -1.86 | -2.48 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | £ 496.42K | £ 676.09K | £ 261.32K | £ 518.30K | £ 957.04K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.50 | 1.29 | 1.50 | 1.27 | 1.14 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | -18194.03 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | -20327.76 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.53 | 1.03 | 0.28 | 0.73 | 1.98 |
| Profitability Margins | |||||
| Gross Profit Margin | -84.70% | -55.49% | -124.70% | -97.37% | -51.67% |
| EBIT Margin | -84.70% | -58.32% | -123.10% | -95.76% | -43.25% |
| EBITDA Margin | -83.75% | -57.17% | -121.46% | -94.01% | -41.90% |
| Operating Profit Margin | -84.70% | -58.39% | -123.48% | -96.05% | -43.25% |
| Pretax Profit Margin | -78.73% | -58.32% | -123.10% | -95.76% | -43.24% |
| Net Profit Margin | -74.06% | -52.97% | -112.17% | -79.90% | -30.49% |
| Continuous Operations Profit Margin | -74.06% | -52.97% | -112.17% | -79.90% | -30.49% |
| Net Income Per EBT | 94.06% | 90.81% | 91.12% | 83.44% | 70.52% |
| EBT Per EBIT | 92.96% | 99.89% | 99.69% | 99.70% | 99.96% |
| Return on Assets (ROA) | -88.39% | -46.55% | -144.19% | -70.77% | -22.69% |
| Return on Equity (ROE) | -133.03% | -59.99% | -215.68% | -89.76% | -25.97% |
| Return on Capital Employed (ROCE) | -152.14% | -66.14% | -237.43% | -107.90% | -36.84% |
| Return on Invested Capital (ROIC) | -143.11% | -60.06% | -213.45% | -88.80% | -25.98% |
| Return on Tangible Assets | -88.63% | -46.72% | -145.70% | -71.35% | -22.76% |
| Earnings Yield | -42.47% | -37.50% | -37.51% | -50.24% | -8.81% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.75 | 2.16 | 3.60 | 4.04 | 2.03 |
| Payables Turnover | 20.28 | 14.34 | 35.09 | 65.03 | 46.91 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 111.33 | 61.25 | 32.28 | 77.01 | 57.80 |
| Asset Turnover | 1.19 | 0.88 | 1.29 | 0.89 | 0.74 |
| Working Capital Turnover Ratio | 1.61 | 1.67 | 1.39 | 0.81 | 0.79 |
| Cash Conversion Cycle | 114.77 | 143.68 | 91.00 | 84.69 | 172.45 |
| Days of Sales Outstanding | 132.76 | 169.13 | 101.40 | 90.30 | 180.23 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 18.00 | 25.45 | 10.40 | 5.61 | 7.78 |
| Operating Cycle | 132.76 | 169.13 | 101.40 | 90.30 | 180.23 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -126.83 | -138.79 | -31.67 | -39.92 | -37.27 |
| Capital Expenditure Coverage Ratio | -126.83 | -138.79 | -31.67 | -39.92 | -37.27 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | -143.30 | -36.02 | 0.00 |
| Operating Cash Flow to Sales Ratio | -0.60 | -0.70 | -1.01 | -0.44 | -0.42 |
| Free Cash Flow Yield | -34.50% | -49.67% | -34.81% | -28.58% | -12.48% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.38 | -2.74 | -2.67 | -1.99 | -11.35 |
| Price-to-Sales (P/S) Ratio | 1.74 | 1.41 | 2.99 | 1.59 | 3.46 |
| Price-to-Book (P/B) Ratio | 3.13 | 1.60 | 5.75 | 1.79 | 2.95 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.90 | -2.01 | -2.87 | -3.50 | -8.01 |
| Price-to-Operating Cash Flow Ratio | -2.92 | -2.03 | -2.96 | -3.59 | -8.22 |
| Price-to-Earnings Growth (PEG) Ratio | -0.13 | 0.04 | 0.33 | -0.02 | -0.62 |
| Enterprise Value Multiple | -1.55 | -1.44 | -2.18 | -0.96 | -6.28 |
| Enterprise Value | 1.22M | 646.21K | 1.44M | 540.65K | 2.18M |
| EV to EBITDA | -1.55 | -1.44 | -2.18 | -0.96 | -6.28 |
| EV to Sales | 1.30 | 0.82 | 2.65 | 0.91 | 2.63 |
| EV to Free Cash Flow | -2.16 | -1.17 | -2.54 | -1.99 | -6.09 |
| EV to Operating Cash Flow | -2.18 | -1.18 | -2.62 | -2.04 | -6.26 |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Shareholders’ Equity Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.06 | 0.09 | 0.09 | 0.17 | 0.29 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 0.94 | 0.91 | 0.91 | 0.83 | 0.71 |
| Interest Burden | 0.93 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.01 | 0.02 | 0.02 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.04 | 0.06 | 0.07 |
| Income Quality | 0.81 | 1.32 | 0.90 | 0.55 | 1.38 |
Currency in GBP
